Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Receivables - Other: 2011-2014

Historic Receivables - Other for Vanda Pharmaceuticals (VNDA) over the last 3 years, with Dec 2014 value amounting to $1.6 million.

  • Vanda Pharmaceuticals' Receivables - Other fell 20.00% to $1.6 million in Q4 2014 from the same period last year, while for Dec 2014 it was $1.6 million, marking a year-over-year decrease of 20.00%. This contributed to the annual value of $1.6 million for FY2014, which is 20.00% down from last year.
  • According to the latest figures from FY2014, Vanda Pharmaceuticals' Receivables - Other is $1.6 million, which was down 20.00% from $2.0 million recorded in FY2013.
  • In the past 5 years, Vanda Pharmaceuticals' Receivables - Other ranged from a high of $2.0 million in FY2013 and a low of $116,000 during FY2011.
  • In the last 2 years, Vanda Pharmaceuticals' Receivables - Other had a median value of $1.8 million in 2013 and averaged $1.8 million.
  • Data for Vanda Pharmaceuticals' Receivables - Other shows a maximum YoY declined of 20.00% (in 2014) over the last 5 years.
  • Yearly analysis of 3 years shows Vanda Pharmaceuticals' Receivables - Other stood at $116,000 in 2011, then reached $2.0 million in 2013, then declined by 20.00% to $1.6 million in 2014.